Content Click below to navigate through the document Company overview Financial review Conclusions Investor presentation October 28, 2025 Novartis Q3 Results | October 28, 2025 1 Content Click below to navigate through the document Appendix References Q3 2025 Results Company overview Financial review Conclusions Appendix References Disclaimer This presentation contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, that can generally be i ...